Defence Therapeutics Inc (DTC.CX)
0.51
+0.01
(+2.00%)
CAD |
CNSX |
Aug 25, 16:00
Defence Therapeutics Shareholders Equity (Quarterly) : 5.415M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 5.415M |
| December 31, 2025 | -1.224M |
| September 30, 2025 | -1.407M |
| June 30, 2025 | -1.256M |
| March 31, 2025 | -0.2197M |
| December 31, 2024 | -3.454M |
| September 30, 2024 | -4.121M |
| June 30, 2024 | -3.584M |
| March 31, 2024 | -2.297M |
| December 31, 2023 | -2.295M |
| September 30, 2023 | -0.4415M |
| June 30, 2023 | 1.566M |
| Date | Value |
|---|---|
| March 31, 2023 | 1.331M |
| December 31, 2022 | -2.102M |
| September 30, 2022 | -0.932M |
| June 30, 2022 | -0.3876M |
| March 31, 2022 | 1.514M |
| December 31, 2021 | 2.919M |
| September 30, 2021 | 4.552M |
| June 30, 2021 | 5.487M |
| March 31, 2021 | 6.598M |
| December 31, 2020 | 7.092M |
| September 30, 2020 | |
| June 30, 2020 | 1.864M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Spectral Medical, Inc. | -70.07M |
| Resverlogix Corp. | -133.75M |
| Theratechnologies, Inc. | -38.39M |
| COSCIENS Biopharma, Inc. | 21.06M |
| Restart Life Sciences Corp. | 1.543M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 9.446M |
| Total Liabilities (Quarterly) | 4.031M |
| Debt to Equity Ratio | 0.2889 |
| Current Ratio | 3.367 |
| Net Debt Paydown Yield | -0.13% |